Linamet Tablet is a combination of Linagliptin and Metformin Hydrochloride used for the management of type 2 diabetes mellitus. This fixed-dose combination helps improve glycemic control in patients who are not adequately managed with diet, exercise, or single-agent therapy.
It provides a dual mechanism of action to effectively control both fasting and post-meal blood glucose levels.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Composition
-
Active Ingredients: Linagliptin + Metformin Hydrochloride
-
Strength: 2.5 mg + 850 mg
-
Dosage Form: Oral tablet
Mechanism of Action
This combination works through complementary pathways:
Linagliptin:
-
Inhibits DPP-4 enzyme
-
Increases incretin hormones (GLP-1 and GIP)
-
Enhances glucose-dependent insulin secretion
-
Reduces glucagon secretion
Metformin:
-
Reduces hepatic glucose production
-
Improves peripheral insulin sensitivity
-
Decreases intestinal absorption of glucose
Together, they provide balanced and effective control of blood sugar levels.
Indications
Linamet Tablet is indicated for:
-
Type 2 diabetes mellitus
-
Patients inadequately controlled on Metformin alone
-
Patients requiring combination therapy for improved glycemic control
-
Adjunct to diet and exercise in adult diabetic patients
Dosage and Administration
-
Dosage is individualized based on blood glucose response
-
Usually taken once or twice daily with meals
-
Swallow whole with water; do not crush or chew
-
Regular monitoring of blood glucose is recommended
-
Dose adjustment may be required based on renal function
Benefits
-
Dual mechanism for effective blood sugar control
-
Improves fasting and postprandial glucose levels
-
Convenient fixed-dose combination reduces pill burden
-
Linagliptin has low risk of hypoglycemia when used alone
-
Supports long-term diabetes management
Side Effects
Common side effects may include:
-
Nausea or vomiting
-
Diarrhea
-
Abdominal discomfort
-
Headache
-
Nasopharyngitis
Less common but serious effects:
-
Lactic acidosis (rare, related to Metformin)
-
Pancreatitis (rare, related to Linagliptin)
-
Hypoglycemia (especially when combined with insulin or sulfonylureas)
-
Allergic reactions
Precautions and Warnings
-
Use only under medical supervision
-
Monitor renal function regularly
-
Avoid excessive alcohol intake (risk of lactic acidosis)
-
Temporarily discontinue before contrast imaging procedures if advised
-
Caution in patients with liver or kidney impairment
-
Not indicated for type 1 diabetes or diabetic ketoacidosis
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Use in Special Populations
-
Pregnancy: Insulin is preferred; use only if prescribed
-
Lactation: Consult physician before use
-
Pediatrics: Not recommended
-
Elderly: Requires regular renal monitoring and possible dose adjustment
Storage
-
Store below 25°C
-
Protect from moisture and light
-
Keep in original packaging
-
Keep out of reach of children.